Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
Predicting school readiness from neurodevelopmental assessments at age 2 years after respiratory distress syndrome in infants born preterm.
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
Toxicity of high dose BCNU: how much is too much?
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Toxicity of high dose BCNU: how much is too much?
Toxicity of high dose BCNU: how much is too much? Leuk Lymphoma. 2006 Aug; 47(8):1447-8.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carmustine
Hematopoietic Stem Cell Transplantation
Humans
Maximum Tolerated Dose
Transplantation Conditioning
authors with profiles
Koen Van Besien